Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.05 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |